Literature DB >> 22096455

Possible Mechanisms of Local Tissue Renin-Angiotensin System Activation in the Cardiorenal Metabolic Syndrome and Type 2 Diabetes Mellitus.

Melvin R Hayden1, Kurt M Sowers, Lakshmi Pulakat, Tejaswini Joginpally, Bennett Krueger, Adam Whaley-Connell, James R Sowers.   

Abstract

The role of local tissue renin-angiotensin system (tRAS) activation in the cardiorenal metabolic syndrome (CRS) and type 2 diabetes mellitus (T2DM) is not well understood. To this point, we posit that early redox stress-mediated injury to tissues and organs via accumulation of excessive reactive oxygen species (ROS) and associated wound healing responses might serve as a paradigm to better understand how tRAS is involved. There are at least five common categories responsible for generating ROS that may result in a positive feedback ROS-tRAS axis. These mechanisms include metabolic substrate excess, hormonal excess, hypoxia-ischemia/reperfusion, trauma, and inflammation. Because ROS are toxic to proteins, lipids, and nucleic acids they may be the primary instigator, serving as the injury nidus to initiate the wound healing process. Insulin resistance is central to the development of the CRS and T2DM, and there are now thought to be four major organ systems important in their development. In states of overnutrition and tRAS activation, adipose tissue, skeletal muscle (SkM), islet tissues, and liver (the quadrumvirate) are individually and synergistically related to the development of insulin resistance, CRS, and T2DM. The obesity epidemic is thought to be the driving force behind the CRS and T2DM, which results in the impairment of multiple end-organs, including the cardiovascular system, pancreas, kidney, retina, liver, adipose tissue, SkM, and nervous system. A better understanding of the complex mechanisms leading to local tRAS activation and increases in tissue ROS may lead to new therapies emphasizing global risk reduction of ROS resulting in decreased morbidity and mortality.

Entities:  

Year:  2011        PMID: 22096455      PMCID: PMC3169372          DOI: 10.1159/000329926

Source DB:  PubMed          Journal:  Cardiorenal Med        ISSN: 1664-5502            Impact factor:   2.041


  112 in total

Review 1.  Physiopathology of the renin-angiotensin system in the ovary.

Authors:  I De Nuccio; G Salvati; G Genovesi; P Paolini; L Marcellini; V Schiavello; M Re
Journal:  Minerva Endocrinol       Date:  1999-06       Impact factor: 2.184

2.  History about the discovery of the renin-angiotensin system.

Authors:  N Basso; N A Terragno
Journal:  Hypertension       Date:  2001-12-01       Impact factor: 10.190

Review 3.  Physiology of local renin-angiotensin systems.

Authors:  Martin Paul; Ali Poyan Mehr; Reinhold Kreutz
Journal:  Physiol Rev       Date:  2006-07       Impact factor: 37.312

Review 4.  Renal redox stress and remodeling in metabolic syndrome, type 2 diabetes mellitus, and diabetic nephropathy: paying homage to the podocyte.

Authors:  Melvin R Hayden; Adam Whaley-Connell; James R Sowers
Journal:  Am J Nephrol       Date:  2005 Nov-Dec       Impact factor: 3.754

5.  Cloning and sequence analysis of cDNA for human renin precursor.

Authors:  T Imai; H Miyazaki; S Hirose; H Hori; T Hayashi; R Kageyama; H Ohkubo; S Nakanishi; K Murakami
Journal:  Proc Natl Acad Sci U S A       Date:  1983-12       Impact factor: 11.205

6.  Activation of local renin-angiotensin system by chronic hypoxia in rat pancreas.

Authors:  W P Chan; M L Fung; R Nobiling; P S Leung
Journal:  Mol Cell Endocrinol       Date:  2000-02-25       Impact factor: 4.102

Review 7.  The cardiac renin-angiotensin system: novel signaling mechanisms related to cardiac growth and function.

Authors:  D E Dostal
Journal:  Regul Pept       Date:  2000-07-28

8.  Improved islet morphology after blockade of the renin- angiotensin system in the ZDF rat.

Authors:  Christos Tikellis; Peter J Wookey; Riccardo Candido; Sof Andrikopoulos; Merlin C Thomas; Mark E Cooper
Journal:  Diabetes       Date:  2004-04       Impact factor: 9.461

9.  Treatment of non-alcoholic fatty liver disease.

Authors:  Keith G Tolman; Anthony S Dalpiaz
Journal:  Ther Clin Risk Manag       Date:  2007-12       Impact factor: 2.423

Review 10.  Liver disease and the renin-angiotensin system: recent discoveries and clinical implications.

Authors:  John S Lubel; Chandana B Herath; Louise M Burrell; Peter W Angus
Journal:  J Gastroenterol Hepatol       Date:  2008-06-28       Impact factor: 4.029

View more
  22 in total

1.  Bone Marrow-Derived Cells Restore Functional Integrity of the Gut Epithelial and Vascular Barriers in a Model of Diabetes and ACE2 Deficiency.

Authors:  Yaqian Duan; Ram Prasad; Dongni Feng; Eleni Beli; Sergio Li Calzi; Ana Leda F Longhini; Regina Lamendella; Jason L Floyd; Mariana Dupont; Sunil K Noothi; Gopalkrishna Sreejit; Baskaran Athmanathan; Justin Wright; Amanda R Jensen; Gavin Y Oudit; Troy A Markel; Prabhakara R Nagareddy; Alexander G Obukhov; Maria B Grant
Journal:  Circ Res       Date:  2019-10-15       Impact factor: 17.367

2.  Salt Loading Promotes Kidney Injury via Fibrosis in Young Female Ren2 Rats.

Authors:  Javad Habibi; Melvin R Hayden; Carlos M Ferrario; James R Sowers; Adam T Whaley-Connell
Journal:  Cardiorenal Med       Date:  2014-03-14       Impact factor: 2.041

Review 3.  The pathophysiology of hypertension in patients with obesity.

Authors:  Vincent G DeMarco; Annayya R Aroor; James R Sowers
Journal:  Nat Rev Endocrinol       Date:  2014-04-15       Impact factor: 43.330

4.  Targeted deletion of murine CEACAM 1 activates PI3K-Akt signaling and contributes to the expression of (Pro)renin receptor via CREB family and NF-κB transcription factors.

Authors:  Jiqian Huang; Kelly J Ledford; William B Pitkin; Lucia Russo; Sonia M Najjar; Helmy M Siragy
Journal:  Hypertension       Date:  2013-06-03       Impact factor: 10.190

Review 5.  Nicotine and the renin-angiotensin system.

Authors:  Joshua M Oakes; Robert M Fuchs; Jason D Gardner; Eric Lazartigues; Xinping Yue
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2018-08-08       Impact factor: 3.619

6.  Blunting of estrogen modulation of cardiac cellular chymase/RAS activity and function in SHR.

Authors:  Sarfaraz Ahmad; Xuming Sun; Marina Lin; Jasmina Varagic; Gisele Zapata-Sudo; Carlos M Ferrario; Leanne Groban; Hao Wang
Journal:  J Cell Physiol       Date:  2017-10-04       Impact factor: 6.384

Review 7.  Ischemia and reactive oxygen species in sympathetic hyperactivity states: a vicious cycle that can be interrupted by renal denervation?

Authors:  Lisette E G Hubens; Willemien L Verloop; Jaap A Joles; Peter J Blankestijn; Michiel Voskuil
Journal:  Curr Hypertens Rep       Date:  2013-08       Impact factor: 5.369

8.  Anti-inflammatory γ- and δ-tocotrienols improve cardiovascular, liver and metabolic function in diet-induced obese rats.

Authors:  Weng-Yew Wong; Leigh C Ward; Chee Wai Fong; Wei Ney Yap; Lindsay Brown
Journal:  Eur J Nutr       Date:  2015-10-08       Impact factor: 5.614

9.  The prevalence and predictors of resistant hypertension in high-risk overweight and obese patients: A cross-sectional study based on the 2017 ACC/AHA guidelines.

Authors:  Faris Haddadin; Karan Sud; Alba Munoz Estrella; Sananda Moctezuma; Lingling Wu; Joshua Berookhim; Claire Huang Lucas; Dipal Patel; Edgar Argulian
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-08-26       Impact factor: 3.738

10.  Evaluating hormonal mechanisms of vitamin D receptor agonist therapy in diabetic kidney disease: the VALIDATE-D study.

Authors:  Jenifer M Brown; Kristina Secinaro; Jonathan S Williams; Anand Vaidya
Journal:  BMC Endocr Disord       Date:  2013-08-23       Impact factor: 2.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.